Catalog Number Pack Size List Price* Quantity
HY-B1625-1MG 1 mg 115,00 Add
HY-B1625-5MG 5 mg 283,00 Add
HY-B1625-10MG 10 mg 451,00 Add

* CHF, excl. 7.7% VAT and shipping costs

Product Description

35% discount on MedChem product orders above CHF 1'000 !
- 1st November - 31st December 2023
- Not cumulative with the "30% off Screening Libraries Promotion"

Deferoxamine B; Deferriferrioxamine B; Deferrioxamine
Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].

Category Biochemicals
Supplier MedChem Express
Regulatory Status RUO
Research Field Cancer, Infection, Metabolic Disease, Inflammation/Immunology, Neurological Disease, Apoptosis,Autophagy,Immunology/Inflammation,Metabolic Enzyme/Protease,NF-κB,PI3K/Akt/mTOR
Format Solubility: 10 mM in DMSO
Grade Clinical information: Launched
Purity 98%
Molecular Formula C25H48N6O8
Molecular Weight 560.68
CAS-Number 70-51-9
Storage Conditions -20°C, 3 years; 4°C, 2 years (Powder)
Tech. Data Sheet View datasheet
Link To Supplier
Shipping Details Room Temperature
Material Safety Data Sheet Download PDF